Franklin Resources Portfolio holdings
Franklin Resources, Inc., commonly known as Franklin Templeton, was founded in 1947 by Rupert H. Johnson, Sr., and is headquartered in San Mateo, California, operating as a global investment management firm managing hundreds of billions in assets. The company offers a wide range of investment products, including mutual funds, ETFs, fixed-income portfolios, and alternative investments, serving individual investors, financial advisors, and institutions across over 150 countries. Known for its acquisition-driven growth—such as the 1992 purchase of Templeton Investments and the 2020 addition of Legg Mason—Franklin Templeton combines diverse strategies under a single brand, emphasizing both active management and income-focused solutions like its flagship Franklin Income Fund. With a reputation for adaptability and a client-centric approach, it remains a major player in the global asset management industry.
Top Buys
| 1 |
Chevron
CVX
|
$740M |
| 2 |
JPMorgan Chase
JPM
|
$707M |
| 3 |
PepsiCo
PEP
|
$649M |
| 4 |
American Electric Power
AEP
|
$592M |
| 5 |
Duke Energy
DUK
|
$523M |
Top Sells
| 1 |
Pfizer
PFE
|
$393M |
| 2 |
Wells Fargo
WFC
|
$357M |
| 3 |
Alibaba
BABA
|
$341M |
| 4 |
Oracle
ORCL
|
$320M |
| 5 |
Air Products & Chemicals
APD
|
$299M |
Sector Composition
| 1 | Technology | 20.39% |
| 2 | Healthcare | 15.35% |
| 3 | Financials | 10.52% |
| 4 | Consumer Discretionary | 9.17% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
276
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $155M | 0.08% |
1,997,236
+670,254
| +51% | +$52.1M |
|
277
British American Tobacco
BTI
$122B
| $155M | 0.07% |
4,280,658
+12,464
| +0.3% | +$451K |
|
278
Enbridge
ENB
$105B
| $153M | 0.07% |
5,256,761
-177,776
| -3% | -$5.19M |
|
279
Scotiabank
BNS
$78.8B
| $153M | 0.07% |
3,678,642
-143,351
| -4% | -$5.95M |
|
|
NBIS
280
Nebius Group N.V. Class A Ordinary Shares
NBIS
$15.6B
| $152M | 0.07% |
2,331,691
-213,438
| -8% | -$13.9M |
|
281
Donaldson
DCI
$9.44B
| $151M | 0.07% |
3,259,111
-11,087
| -0.3% | -$515K |
|
|
IMMU
282
DELISTED
Immunomedics Inc
IMMU
| $150M | 0.07% |
1,769,944
-675,642
| -28% | -$57.5M |
|
283
Haemonetics
HAE
$2.62B
| $150M | 0.07% |
1,723,851
+438,864
| +34% | +$38.3M |
|
284
Franklin High Yield Corporate ETF
FLHY
$626M
| $150M | 0.07% |
5,931,184
+125,610
| +2% | +$3.18M |
|
|
BKI
285
DELISTED
Black Knight, Inc. Common Stock
BKI
| $149M | 0.07% |
1,713,394
+74,862
| +5% | +$6.52M |
|
286
Franklin FTSE Japan ETF
FLJP
$2.34B
| $149M | 0.07% |
5,690,653
+119,081
| +2% | +$3.12M |
|
|
SRE.PRB
287
DELISTED
Sempra 6.75% Mandatory Convertible Preferred Stock, Series B
SRE.PRB
| $149M | 0.07% |
1,516,750
+100,100
| +7% | +$9.81M |
|
288
Guardant Health
GH
$7.5B
| $148M | 0.07% |
1,326,049
+429,441
| +48% | +$48M |
|
289
Southwest Airlines
LUV
$16.5B
| $148M | 0.07% |
3,945,766
+3,460,649
| +713% | +$130M |
|
|
AYX
290
DELISTED
Alteryx, Inc.
AYX
| $148M | 0.07% |
1,301,724
-142,463
| -10% | -$16.2M |
|
291
Neurocrine Biosciences
NBIX
$14.3B
| $147M | 0.07% |
1,530,160
+77,878
| +5% | +$7.49M |
|
|
NVRO
292
DELISTED
NEVRO CORP.
NVRO
| $147M | 0.07% |
1,052,266
-35,338
| -3% | -$4.92M |
|
293
Bank of Montreal
BMO
$90.3B
| $146M | 0.07% |
2,501,656
-93,088
| -4% | -$5.44M |
|
294
Schwab Short-Term US Treasury ETF
SCHO
$11.7B
| $146M | 0.07% |
5,665,050
+224,750
| +4% | +$5.79M |
|
295
Aflac
AFL
$57.2B
| $146M | 0.07% |
4,011,292
+34,722
| +0.9% | +$1.26M |
|
296
Evergy
EVRG
$16.5B
| $145M | 0.07% |
2,852,759
+293,049
| +11% | +$14.9M |
|
297
BorgWarner
BWA
$9.53B
| $145M | 0.07% |
4,247,278
+597,290
| +16% | +$20.4M |
|
298
Agilent Technologies
A
$36.5B
| $144M | 0.07% |
1,430,108
+6,066
| +0.4% | +$612K |
|
299
Boeing
BA
$174B
| $143M | 0.07% |
866,981
+847,610
| +4,376% | +$140M |
|
300
Inspire Medical Systems
INSP
$2.56B
| $143M | 0.07% |
1,106,971
+122,375
| +12% | +$15.8M |
|